» Articles » PMID: 33991710

Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry

Overview
Specialty Ophthalmology
Date 2021 May 15
PMID 33991710
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Retinal vascular occlusion is a leading cause of profound irreversible visual loss, but the understanding of the disease is insufficient. We systematically investigated the age, gender, and laterality at the onset of retinal artery occlusion (RAO) and retinal vein occlusion (RVO) in the Intelligent Research in Sight (IRIS®) Registry.

Design: Retrospective registry cohort.

Participants: Patients with retinal vascular occlusion participating in the IRIS® Registry.

Methods: Patients who received a diagnosis of retinal vascular occlusion between 2013 and 2017 were included. Those with unspecified gender or laterality were excluded when conducting the relevant analyses. Patients were categorized into RAO, with subtypes transient retinal artery occlusion (TRAO), partial retinal artery occlusion (PRAO), branch retinal artery occlusion (BRAO), and central retinal artery occlusion (CRAO), and into RVO, with subtypes venous engorgement (VE), branch retinal vein occlusion (BRVO), and central retinal vein occlusion (CRVO). Age was evaluated as a categorical variable (5-year increments). We investigated the association of age, gender, and laterality with the onset frequency of retinal vascular occlusion subtypes.

Main Outcome Measures: The frequency of onset of RAO and RVO subtypes by age, gender and laterality.

Results: A total of 1 251 476 patients with retinal vascular occlusion were included, 23.8% of whom had RAO, whereas 76.2% had RVO. Of these, 1 248 656 and 798 089 patients were selected for analyses relevant to gender and laterality, respectively. The onset frequency of all subtypes increased with age. PRAO, BRAO, CRAO, and CRVO presented more frequently in men (53.5%, 51.3%, 52.6%, and 50.4%, respectively), whereas TRAO, VE, and BRVO presented more frequently in women (54.9%, 56.0%, and 54.5% respectively). All RAO subtypes and BRVO showed a right-eye onset preference (TRAO, 51.7%; PRAO, 54.4%; BRAO, 53.5%; CRAO, 53.4%; and BRVO, 51.0%), whereas VE and CRVO exhibited a left-eye onset preference (53.3% and 50.9%, respectively).

Conclusions: Although retinal vascular occlusion incidence increases with age regardless of subtypes, we found various subtype-specific disease-onset differences related to gender and, in particular, ocular laterality. These findings may improve understanding of the specific cause of retinal vascular occlusions of different subtypes and their relationships with structural and anatomic asymmetries of the vascular system.

Citing Articles

Profile and outcomes of retinal artery occlusion: The underrealized need to expedite presentation.

Kadam Y, Das A, Narayanan R, Balakrishnan N, Telukunta P, Takkar B Indian J Ophthalmol. 2024; 73(Suppl 1):S72-S77.

PMID: 39723868 PMC: 11834905. DOI: 10.4103/IJO.IJO_1686_24.


Branch Retinal Artery Occlusion as a Presentation of Seronegative Antiphospholipid Syndrome in Pregnancy.

Chewa Raja J, Redzuan M, Rafique Ali A Cureus. 2024; 16(11):e74198.

PMID: 39712706 PMC: 11663242. DOI: 10.7759/cureus.74198.


Impact of high-risk optic disc on central retinal vein occlusion in patients with metabolic disorders.

Si S, Lin J, Guo R, Chen A, Ji Y Front Physiol. 2024; 15:1424144.

PMID: 39210970 PMC: 11358100. DOI: 10.3389/fphys.2024.1424144.


Vitamin D deficiency in patients with retinal vein occlusion: a systematic review and meta-analysis.

Daneshvar K, Akhlaghi M, Iranpour S, Irajpour M, Pourazizi M Int J Retina Vitreous. 2024; 10(1):52.

PMID: 39068491 PMC: 11282712. DOI: 10.1186/s40942-024-00571-3.


Optimizing open-angle glaucoma risk assessment in patients with retinal vein occlusions.

Muhtaseb R, Huther A, Alwreikat A, Ramsey D Eye (Lond). 2024; 38(15):2985-2991.

PMID: 38982301 PMC: 11461672. DOI: 10.1038/s41433-024-03205-y.


References
1.
Parke 3rd D, Lum F . Return to the Operating Room after Macular Surgery: IRIS Registry Analysis. Ophthalmology. 2018; 125(8):1273-1278. DOI: 10.1016/j.ophtha.2018.01.009. View

2.
Dong N, Xu B, Tang X . Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population. Invest Ophthalmol Vis Sci. 2014; 55(7):4057-62. DOI: 10.1167/iovs.14-14226. View

3.
Chang Y, Jan R, Weng S, Wang J, Chio C, Wei F . Retinal artery occlusion and the 3-year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol. 2012; 154(4):645-652.e1. DOI: 10.1016/j.ajo.2012.03.046. View

4.
Bucciarelli P, Passamonti S, Gianniello F, Artoni A, Martinelli I . Thrombophilic and cardiovascular risk factors for retinal vein occlusion. Eur J Intern Med. 2017; 44:44-48. DOI: 10.1016/j.ejim.2017.06.022. View

5.
Marcucci R, Sodi A, Giambene B, Liotta A, Poli D, Mannini L . Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis. 2007; 18(4):321-6. DOI: 10.1097/MBC.0b013e32809cc922. View